Detalhe da pesquisa
1.
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma.
Blood
; 139(13): 1999-2010, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780623
2.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood
; 139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570876
3.
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.
Am J Hematol
; 98(2): 300-308, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588409
4.
Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing.
Aesthet Surg J
; 43(3): 318-328, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351182
5.
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 26(12): 2223-2228, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829079
6.
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
Haematologica
; 109(3): 953-957, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706336
7.
Formulating a Treatment Plan in Suspected Lymphoma: Ultrasound-Guided Core Needle Biopsy Versus Core Needle Biopsy and Fine-Needle Aspiration of Peripheral Lymph Nodes.
J Ultrasound Med
; 38(3): 581-586, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043431
8.
Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with ß-catenin.
J Cell Sci
; 126(Pt 24): 5598-609, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101723
9.
Molecular mechanisms of osteoblast/osteocyte regulation by connexin43.
Calcif Tissue Int
; 94(1): 55-67, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23754488
10.
Neoantigen Landscape Supports Feasibility of Personalized Cancer Vaccine for Follicular Lymphoma.
Blood Adv
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713894
11.
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies.
Clin Lymphoma Myeloma Leuk
; 23(7): 552-560, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183115
12.
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.
Leuk Lymphoma
; 64(1): 107-118, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323309
13.
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Blood Adv
; 7(18): 5524-5539, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493986
14.
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.
Cancer Res Commun
; 3(11): 2312-2330, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910143
15.
N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms.
J Cell Sci
; 123(Pt 15): 2640-8, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20605916
16.
Nutrient regulates Tor1 nuclear localization and association with rDNA promoter.
Nature
; 442(7106): 1058-61, 2006 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-16900101
17.
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
Cancers (Basel)
; 14(12)2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740596
18.
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
Clin Lymphoma Myeloma Leuk
; 22(7): e435-e442, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35093285
19.
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
Blood Adv
; 6(7): 2035-2044, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196377
20.
Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling.
J Biol Chem
; 285(31): 23858-67, 2010 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20501659